chr17-80997298-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_024591.5(CHMP6):c.452A>T(p.Glu151Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000023 in 1,611,242 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
CHMP6
NM_024591.5 missense
NM_024591.5 missense
Scores
1
14
4
Clinical Significance
Conservation
PhyloP100: 8.79
Genes affected
CHMP6 (HGNC:25675): (charged multivesicular body protein 6) This gene encodes a member of the chromatin-modifying protein/charged multivesicular body protein family. Proteins in this family are part of the ESCRT-III (endosomal sorting complex required for transport III) which degrades surface receptors, and in biosynthesis of endosomes. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP6 | NM_024591.5 | c.452A>T | p.Glu151Val | missense_variant | 6/8 | ENST00000325167.9 | NP_078867.2 | |
CHMP6 | XM_005257668.1 | c.452A>T | p.Glu151Val | missense_variant | 6/7 | XP_005257725.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP6 | ENST00000325167.9 | c.452A>T | p.Glu151Val | missense_variant | 6/8 | 1 | NM_024591.5 | ENSP00000317468.5 | ||
CHMP6 | ENST00000572778.5 | c.389A>T | p.Glu130Val | missense_variant | 5/6 | 2 | ENSP00000461098.1 | |||
CHMP6 | ENST00000571457.1 | c.326A>T | p.Glu109Val | missense_variant | 5/7 | 3 | ENSP00000461238.1 | |||
CHMP6 | ENST00000572525.5 | c.194A>T | p.Glu65Val | missense_variant | 6/8 | 3 | ENSP00000460389.1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 150716Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
150716
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 246960Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133744
GnomAD3 exomes
AF:
AC:
6
AN:
246960
Hom.:
AF XY:
AC XY:
3
AN XY:
133744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1460526Hom.: 0 Cov.: 34 AF XY: 0.0000206 AC XY: 15AN XY: 726592
GnomAD4 exome
AF:
AC:
33
AN:
1460526
Hom.:
Cov.:
34
AF XY:
AC XY:
15
AN XY:
726592
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000265 AC: 4AN: 150716Hom.: 0 Cov.: 32 AF XY: 0.0000407 AC XY: 3AN XY: 73628
GnomAD4 genome
AF:
AC:
4
AN:
150716
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
73628
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 23, 2024 | The c.452A>T (p.E151V) alteration is located in exon 6 (coding exon 6) of the CHMP6 gene. This alteration results from a A to T substitution at nucleotide position 452, causing the glutamic acid (E) at amino acid position 151 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;.;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;.
Sift4G
Uncertain
D;T;D;D
Polyphen
0.36
.;B;.;.
Vest4
0.71
MutPred
0.47
.;Loss of solvent accessibility (P = 0.0022);.;.;
MVP
MPC
0.33
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at